JPS6365645B2 - - Google Patents

Info

Publication number
JPS6365645B2
JPS6365645B2 JP54089178A JP8917879A JPS6365645B2 JP S6365645 B2 JPS6365645 B2 JP S6365645B2 JP 54089178 A JP54089178 A JP 54089178A JP 8917879 A JP8917879 A JP 8917879A JP S6365645 B2 JPS6365645 B2 JP S6365645B2
Authority
JP
Japan
Prior art keywords
heart rate
blood pressure
stress
subjects
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54089178A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5515481A (en
Inventor
Sutaare Herumutsuto
Kotsupe Heruberuto
Kumaa Berunaa
Arundotsu Deietoritsuhi
Kobingaa Barutaa
Ririi Kurisuchan
Pihiraa Rudoitsugu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
C.H. Boehringer Sohn AG and Co KG
Original Assignee
C.H. Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C.H. Boehringer Sohn AG and Co KG filed Critical C.H. Boehringer Sohn AG and Co KG
Publication of JPS5515481A publication Critical patent/JPS5515481A/ja
Publication of JPS6365645B2 publication Critical patent/JPS6365645B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP8917879A 1978-07-15 1979-07-13 Heart pulse decreasing agent Granted JPS5515481A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782831190 DE2831190A1 (de) 1978-07-15 1978-07-15 Verwendung von 2-eckige klammer auf n-(2,6-dichlorphenyl)-n-allyl-amino eckige klammer zu-imidazolin-(2) als bradykardes mittel

Publications (2)

Publication Number Publication Date
JPS5515481A JPS5515481A (en) 1980-02-02
JPS6365645B2 true JPS6365645B2 (enExample) 1988-12-16

Family

ID=6044496

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8917879A Granted JPS5515481A (en) 1978-07-15 1979-07-13 Heart pulse decreasing agent

Country Status (5)

Country Link
US (1) US4271175A (enExample)
EP (1) EP0007412B1 (enExample)
JP (1) JPS5515481A (enExample)
AT (1) ATE25501T1 (enExample)
DE (2) DE2831190A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03124103A (ja) * 1989-10-09 1991-05-27 Murata Mfg Co Ltd 非可逆回路素子
CN113271947A (zh) 2018-11-02 2021-08-17 古川研究所有限公司 心率降低剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759125A (fr) * 1969-11-19 1971-05-18 Boehringer Sohn Ingelheim Nouvelles n-allyl-2-arylamino-imidazolines-(2) substituees et procedes pour les fabriquer
US3850926A (en) * 1971-01-21 1974-11-26 Boehringer Sohn Ingelheim 2-(n-substituted-phenylamino)-imidazolines-(2)
DE2404754A1 (de) * 1974-02-01 1975-08-14 Boehringer Sohn Ingelheim Mittel zur verminderung der herzfrequenz

Also Published As

Publication number Publication date
DE2831190A1 (de) 1980-01-24
JPS5515481A (en) 1980-02-02
EP0007412A1 (de) 1980-02-06
EP0007412B1 (de) 1987-02-25
US4271175A (en) 1981-06-02
ATE25501T1 (de) 1987-03-15
DE2967648D1 (en) 1987-04-02

Similar Documents

Publication Publication Date Title
US5153222A (en) Method of treating pulmonary hypertension with benzidine prostaglandins
Winniford et al. Alpha-adrenergic blockade for variant angina: a long-term, double-blind, randomized trial.
WO1997036609A2 (en) Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest
CA2056201A1 (en) Treatment of sleep disorders
US4210670A (en) Antithrombotic agents
Bolli et al. Effects of prazosin in patients with hypertension
US5028628A (en) Methods of treating pulmonary hypertension
US4604394A (en) Antiarrhythmic compositions and method
AU7716598A (en) Anti-arrhythmic composition and methods of treatment
JPS6129927B2 (enExample)
US4380550A (en) Guanfacine in treating opiate addiction
US4175128A (en) Method for treating congestive heart failure
KR100260479B1 (ko) 혈압강하용 복합제제
US4259342A (en) Antianginal treatment with azepine derivatives
EP0303357B1 (en) 4-Amino-6,7-dimethoxy-2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinol-2-yl)quinoline for (treatment of cardiac arrhythmias).
US4271175A (en) Method of using 2-[N-(2,6-dichloro-phenyl)-N-allyl-amino]-2-imidazoline and salts thereof as bradycardiacs
US4375473A (en) Method
US3885045A (en) Therapeutic composition containing 1-(2-hydroxy-2-indanyl)-propylamine
Wheatley A comparison of diltiazem and atenolol in angina
US3969525A (en) Method for reducing the heart beat frequency
Nies et al. Recent concepts in the clinical pharmacology of anithypertensive drugs
Nyberg et al. Circulatory effects of sublingual and oral sustained-release nitroglycerin in healthy young men
Werning The effect of minoxidil on blood pressure and plasma renin activity in patients with essential and renal hypertension
JPS61172820A (ja) カルシウム拮抗剤
Kaiser et al. Development of tolerance and peripheral hemodynamic effects of molsidomine